Imaging of Tumor Spheroids, Dual-Isotope SPECT, and Autoradiographic Analysis to Assess the Tumor Uptake and Distribution of Different Nanobodies
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Imaging of Tumor Spheroids, Dual-Isotope SPECT, and Autoradiographic Analysis to Assess the Tumor Uptake and Distribution of Different Nanobodies
Authors
Keywords
Nanobodies, Spheroids, Dual-isotope SPECT, Tumor imaging
Journal
MOLECULAR IMAGING AND BIOLOGY
Volume -, Issue -, Pages -
Publisher
Springer Nature
Online
2019-03-11
DOI
10.1007/s11307-019-01320-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Pharmacokinetics of radiolabeled dimeric sdAbs constructs targeting human CD20
- (2018) Ahmet Krasniqi et al. New Biotechnology
- Rapid Visualization of Human Tumor Xenografts through Optical Imaging with a Near-Infrared Fluorescent Anti–Epidermal Growth Factor Receptor Nanobody
- (2018) Sabrina Oliveira et al. Molecular Imaging
- Antibody or Antibody Fragments: Implications for Molecular Imaging and Targeted Therapy of Solid Tumors
- (2017) Katerina T. Xenaki et al. Frontiers in Immunology
- EGFR targeted nanobody–photosensitizer conjugates for photodynamic therapy in a pre-clinical model of head and neck cancer
- (2016) Pieter B.A.A. van Driel et al. JOURNAL OF CONTROLLED RELEASE
- 18F-nanobody for PET imaging of HER2 overexpressing tumors
- (2016) Catarina Xavier et al. NUCLEAR MEDICINE AND BIOLOGY
- Molecular imaging of tumors with nanobodies and antibodies: Timing and dosage are crucial factors for improvedin vivodetection
- (2015) Peter Bannas et al. Contrast Media & Molecular Imaging
- Three-Dimensional Cell Culture: A Breakthrough in Vivo
- (2015) Delphine Antoni et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Phase I Study of 68Ga-HER2-Nanobody for PET/CT Assessment of HER2 Expression in Breast Carcinoma
- (2015) M. Keyaerts et al. JOURNAL OF NUCLEAR MEDICINE
- Nanobody: The “Magic Bullet” for Molecular Imaging?
- (2014) Rubel Chakravarty et al. Theranostics
- Advances in imaging probes and optical microendoscopic imaging techniques for early in vivo cancer assessment
- (2013) Numfon Khemthongcharoen et al. ADVANCED DRUG DELIVERY REVIEWS
- Design and evaluation of radiolabeled tracers for tumor imaging
- (2013) Helena Wållberg et al. BIOTECHNOLOGY AND APPLIED BIOCHEMISTRY
- Rapid optical imaging of human breast tumour xenografts using anti-HER2 VHHs site-directly conjugated to IRDye 800CW for image-guided surgery
- (2013) Marta Kijanka et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Targeting tumors with nanobodies for cancer imaging and therapy
- (2013) Sabrina Oliveira et al. JOURNAL OF CONTROLLED RELEASE
- Nanobody-Based Targeting of the Macrophage Mannose Receptor for EffectiveIn VivoImaging of Tumor-Associated Macrophages
- (2012) Kiavash Movahedi et al. CANCER RESEARCH
- Dual-isotope111In/177Lu SPECT imaging as a tool in molecular imaging tracer design
- (2012) Nicole M Hijnen et al. Contrast Media & Molecular Imaging
- Correlation Between Epidermal Growth Factor Receptor-Specific Nanobody Uptake and Tumor Burden: A Tool for Noninvasive Monitoring of Tumor Response to Therapy
- (2010) Lea Olive Tchouate Gainkam et al. MOLECULAR IMAGING AND BIOLOGY
- Strategies for Molecular Imaging of Epidermal Growth Factor Receptor Tyrosine Kinase in Cancer
- (2009) E. Mishani et al. JOURNAL OF NUCLEAR MEDICINE
- Diminishing the impact of the partial volume effect in cardiac SPECT perfusion imaging
- (2009) P. Hendrik Pretorius et al. MEDICAL PHYSICS
- Comparison of the Biodistribution and Tumor Targeting of Two 99mTc-Labeled Anti-EGFR Nanobodies in Mice, Using Pinhole SPECT/Micro-CT
- (2008) L. O. T. Gainkam et al. JOURNAL OF NUCLEAR MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More